Inventage Lab, Inc.

₩19,550As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:389470Healthcare
Country South Korea
PE (Fwd) •••
TSR 4Y CAGR 10.91%
Div yield —
ROE (12.72%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 1.01
PE TTM —
TSR TTM (61.67%)
Mkt cap ₩260.2B
ROIC (17.55%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩20,920
7.01%
(94.99%)
Hold 8|2|10|9|12
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
237.90
261.08
280.75
287.63
14.14%
20.90%
20.95%
25.19%
Revenue₩B
13.58
14.17
14.48
14.41
7.41%
7.92%
8.00%
5.15%
Peers (US$191.8M)
Cap (US$)
PE
217.0M
—
191.2M
61.34x
Capital
TTM
5Y
10Y
Leveragex
2.997
2.597
2.133
EBIT/Intx
3.737
0.633
0.463
Own earn%
4.90
(31.10)
(28.15)
Sh yield%
46.20
17.83
16.82
Owners
Insiders/Inst%
0.24
28.48
Short interest%
4.58
SBC / revenue%
2.63
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
0–9
$1 testx
0.0
Incr. ROIC%
4